In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 3, 2007, Pages 553-555

  van de Sande, Wendy W J ^a   Fahal, Ahmed H ^b   Riley, Thomas V ^c   Verbrugh, Henri ^a   van Belkum, Alex ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Essential oils; Itraconazole; Ketoconazole; MICs; Mycetoma

Indexed keywords

ARTEMISININ; ITRACONAZOLE; TEA TREE OIL; ARTEMISININ DERIVATIVE; SESQUITERPENE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PENETRATION; EUMYCETOMA; FUNGAL STRAIN; FUNGUS ISOLATION; GROWTH INHIBITION; IN VITRO STUDY; MADURELLA MYCETOMATIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SKIN PENETRATION; DRUG EFFECT; HUMAN; MADURELLA; MICROBIOLOGICAL EXAMINATION; MYCETOMA;

ARTEMISININS; HUMANS; MADURELLA; MADUROMYCOSIS; MICROBIAL SENSITIVITY TESTS; SESQUITERPENES; TEA TREE OIL;

EID: 34248230726     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl526     Document Type: Article

References (14)

1. van de Sande WW, Luijendijk A, Ahmed AO et al. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino carbonyl]-2H tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob Agents Chemother 2005; 49: 1364-8.
2. Liu CH, Zou WX, Lu H et al. Antifungal activity of Artemisia annua endophyte cultures against phytopathogenic fungi. J Biotechnol 2001; 88: 277-82.
3. Galal AM, Ross SA, Jacob M et al. Antifungal activity of artemisinin derivatives. J Nat Prod 2005; 68: 1274-6.
4. Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: A review of antimicrobial and other medicinal properties. Clin Microbiol Rev 2006; 19: 50-62.
5. Hammer KA, Carson CF, Riley TV. Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. J Appl Microbiol 2003; 95: 853-60.
6. Ahmed AO, Mukhtar MM, Kools-Sijmons M et al. Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. J Clin Microbiol 1999; 37: 3175-8.
7. van de Sande WW, Gorkink R, Simons G et al. Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size. J Clin Microbiol 2005; 43: 4349-56.
8. Ahmed AO, van de Sande WW, van Vianen W et al. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino carbonyl]-2H tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother 2004; 48: 2742-6.
9. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi: Approved Standard M38-A. NCCLS, Wayne, PA, USA, 2002.
10. Fahal AH. Mycetoma: A thorn in the flesh. Trans R Soc Trop Med Hyg 2004; 98: 3-11.
11. Li W, Mo W, Shen D et al. Yeast model uncovers dual roles of mitochondria in action of artemisinin. PLoS Genet 2005; 1: e36.
12. Efferth T. Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy. Drug Resist Updat 2005; 8: 85-97.
13. van de Sande WW, Janse DJ, Hira V et al. Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progression. J Immunol 2006; 177: 1997-2005.
14. Nielsen JB, Nielsen F. Topical use of tea tree oil reduces the dermal absorption of benzoic acid and methiocarb. Arch Dermatol Res 2006; 297: 395-402.